Flora Growth Corp. Files 8-K on Delisting Concerns
Ticker: ZSTK · Form: 8-K · Filed: Aug 30, 2024 · CIK: 1790169
| Field | Detail |
|---|---|
| Company | Flora Growth Corp. (ZSTK) |
| Form Type | 8-K |
| Filed Date | Aug 30, 2024 |
| Risk Level | high |
| Pages | 3 |
| Reading Time | 4 min |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, listing-rules, corporate-governance
TL;DR
Flora Growth Corp. might be delisted, impacting its stock.
AI Summary
Flora Growth Corp. filed an 8-K on August 26, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The filing also covers the departure of directors, election of directors, appointment of officers, and compensatory arrangements. Additionally, it includes financial statements and exhibits.
Why It Matters
This filing indicates potential issues with Flora Growth Corp.'s continued listing on an exchange, which could impact its stock trading and investor confidence.
Risk Assessment
Risk Level: high — The filing explicitly mentions a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard,' indicating significant risk to the company's exchange listing.
Key Players & Entities
- Flora Growth Corp. (company) — Registrant
- August 26, 2024 (date) — Date of earliest event reported
- 3230 W. Commercial Boulevard, Suite 180 Fort Lauderdale , Florida , United States 33309 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard has Flora Growth Corp. failed to satisfy?
The filing does not specify the exact rule or standard that Flora Growth Corp. has failed to satisfy, only that a notice has been issued.
What is the exact date of the earliest event reported in this 8-K?
The earliest event reported is dated August 26, 2024.
What are the main items covered in this 8-K filing?
The filing covers a notice of delisting or failure to satisfy listing rules, departure/election of directors, appointment of officers, compensatory arrangements, and financial statements/exhibits.
Where are Flora Growth Corp.'s principal executive offices located?
Flora Growth Corp.'s principal executive offices are located at 3230 W. Commercial Boulevard, Suite 180, Fort Lauderdale, Florida, 33309.
Is this filing related to the company's financial performance?
While the filing includes financial statements and exhibits, the primary focus appears to be on listing compliance and corporate governance changes, not a direct report of financial performance like an earnings release.
Filing Stats: 885 words · 4 min read · ~3 pages · Grade level 11.1 · Accepted 2024-08-30 16:05:56
Filing Documents
- form8k.htm (8-K) — 18KB
- 0001062993-24-015927.txt ( ) — 233KB
- flgc-20240826.xsd (EX-101.SCH) — 5KB
- flgc-20240826_cal.xml (EX-101.CAL) — 1KB
- flgc-20240826_def.xml (EX-101.DEF) — 22KB
- flgc-20240826_lab.xml (EX-101.LAB) — 46KB
- flgc-20240826_pre.xml (EX-101.PRE) — 25KB
- form8k_htm.xml (XML) — 3KB
01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. The information regarding Kevin Taylor's resignation contained in Item 5.02 is incorporated herein by reference. After giving effect to Mr. Taylor's resignation, the audit committee of the Board of Directors (the "Board") of Flora Growth Corp., a corporation organized under the laws of the province of Ontario (the "Company"), no longer had three independent members as required by Nasdaq Listing Rule 5605(c)(2)(A). The Company informed Nasdaq of the foregoing on August 27, 2024. Pursuant to Item 5.02 below, on August 29, 2024, the Company appointed a new director and member of the audit committee thereby regaining compliance with Nasdaq Listing Rule 5605(c)(2)(A). Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Resignation of Director On August 26, 2024, Mr. Kevin Taylor resigned as a director of the Company. Mr. Taylor did not resign as a result of any disagreement with the Company or any matter relating to the Company's operations, policies or practices. Appointment of Director On August 29, 2024, the Board appointed Mr. Harold Wolkin as an independent director and member of each of the Company's audit committee, compensation committee and nominating and corporate governance committee. Mr. Wolkin is an accomplished investment banker with over 30 years of experience. He currently serves as director, audit committee chair and a member of several publicly listed companies. Mr. Wolkin is a Chartered Financial Analyst and a member of the Institute of Corporate Directors. In connection with his appointment, the Board has determined that Mr. Wolkin (i) meets the requirements for audit committee service contained in Nasdaq Listing Rule 5605(c)(2)(A); (ii) is an "independent director" as contemplated by Nasdaq Listing Rule 5605(b)(1); and (iii
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits 104 Cover Page Interactive Data File
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. FLORA GROWTH CORP. Date: August 30, 2024 By: /s/ Clifford Starke Name: Clifford Starke Title: Chief Executive Officer